Hikma makes organisational changes in US, CEO to retire

LONDON, UK: Hikma Pharmaceuticals PLC (Hikma) announced the organisational changes to its US business (West Ward Pharmaceuticals) to reflect its enhanced US market positioning and to better align with the global Hikma organisation.

Main changes include the following:

• Michael Raya, CEO of the US business will retire at the end of this year. Raya has led the US business for more than 25 years and in that time, has demonstrated strong leadership that has enabled Hikma to grow into a top 10 generics company in the US.

• From 1 July, the US business will be organised into two entities both of which will report to the chairman and CEO, Said Darwazah. There will be a US generics division and a US injectables division.

• Brian Hoffmann has been promoted to President of the US Generics Division.  Mr Hoffmann brings a wealth of experience in strategy, business development, M&A and marketing.  Since joining West-Ward/Hikma in 2009, he has been instrumental in the growth of the US business.

• Riad Mishlawi has been promoted to the role of CEO, injectables division, responsible for all injectable operations globally, including the newly formed US Injectables Division. Riad brings both breadth and depth to this role, having worked with the company since 1990 and led the injectables division through a period of rapid growth.

• Raya will continue to have oversight of the US business, working closely with the team for the rest of the year to transition the business.

“I would like to thank Mike for his many years of successful leadership of our US business and wish him well in his retirement. The leadership and organisational changes we have announced today will bring greater organisational focus and alignment, establish a scalable structure to enable continued growth, and strengthen the US leadership team,” said Said Darwazah, chairman and CEO of Hikma.

“Together with my colleagues, I am proud of what we were able to accomplish during my time at Hikma/West Ward and leave confident that the company is extremely well-positioned for the future,” said Raya, commenting on his retirement.

© Worldofchemicals News 

Read More: Hikma makes organisational changes in US, CEO to retire